ConductScience.org, home

Paper42908014PubMed

Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.

Kongmalai T and 8 others. Diabetol Metab Syndr, 2026.

Cite this record

ConductScience Library. Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning. Papers, record 42908014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heterogeneity in the treatment effect of sodium-glucose cotransporter-2 inhibitor on chronic kidney disease risk reduction: a prevalent new user cohort study applying double/debiased machine learning.
Journal
Diabetol Metab Syndr
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-24

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kongmalai TTanawan
2Looareesuwan PPanu
3Tansawet AAmarithttps://orcid.org/0000-0002-2040-7970
4Siriyotha SSukanya
5Kunakorntham PPatratorn
6Boonwatcharapai BBurin
7Attia JJohn
8McKay GJGareth J
9Thakkinstian AAmmarin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N42A690510National Research Council of ThailandPubMed

Source PubMed

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1380785909. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.Diabetes Care2024https://conductscience.org/library/papers/38078590PubMed
238501205Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill Adults.JAMA2024https://conductscience.org/library/papers/38501205PubMed
332970396Dapagliflozin in Patients with Chronic Kidney Disease.N Engl J Med2020https://conductscience.org/library/papers/32970396PubMed
436568108Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36568108PubMed
58892489Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes.J Clin Epidemiol1996https://conductscience.org/library/papers/8892489PubMed
638388753Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.Diabetologia2024https://conductscience.org/library/papers/38388753PubMed
730990260Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.N Engl J Med2019https://conductscience.org/library/papers/30990260PubMed
828089956Robust causal inference using directed acyclic graphs: the R package 'dagitty'.Int J Epidemiol2016https://conductscience.org/library/papers/28089956PubMed
918313558The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.J Clin Epidemiol2008https://conductscience.org/library/papers/18313558PubMed
1037161041Machine learning-based causal models for predicting the response of individual patients to dexamethasone treatment as prophylactic antiemetic.Sci Rep2023https://conductscience.org/library/papers/37161041PubMed
1128693043Sensitivity Analysis in Observational Research: Introducing the E-Value.Ann Intern Med2017https://conductscience.org/library/papers/28693043PubMed
1236397062Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes.Cardiovasc Diabetol2022https://conductscience.org/library/papers/36397062PubMed
1316731850Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.Diabetes2006https://conductscience.org/library/papers/16731850PubMed
1438490803KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.Kidney Int2024https://conductscience.org/library/papers/38490803PubMed
1537328784Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine.BMC Med Inform Decis Mak2023https://conductscience.org/library/papers/37328784PubMed
1639624210Associated Factors for Chronic Kidney Disease in Patients with Diabetes Mellitus 2: Retrospective Study.Int J Nephrol Renovasc Dis2024https://conductscience.org/library/papers/39624210PubMed
1735909178Hierarchy of Evidence Within the Medical Literature.Hosp Pediatr2022https://conductscience.org/library/papers/35909178PubMed
1837929568Delayed versus primary closure to minimize risk of surgical-site infection for complicated appendicitis: A secondary analysis of a randomized trial using counterfactual prediction modeling.Infect Control Hosp Epidemiol2024https://conductscience.org/library/papers/37929568PubMed
1935534565Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes.Nat Med2022https://conductscience.org/library/papers/35534565PubMed
2036335315Real-world data: a brief review of the methods, applications, challenges and opportunities.BMC Med Res Methodol2022https://conductscience.org/library/papers/36335315PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908014

GET https://conductscience.org/api/papers/v1/42908014/references?page=2